One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building ...

In the first randomized controlled trial in patients with vestibular migraine, galcanezumab outperformed placebo in reducing ...

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

Researchers reviewed the impact of various diets, including ketogenic and low-fat vegan, on reducing the frequency, intensity ...

Luckily, numerous household ingredients have been discovered to help mitigate the severity and frequency of migraine attacks. This article delves into simple, accessible remedies that can provide ...

Research on melatonin for migraine has had mixed results. However, melatonin is a hormone that can help people fall asleep. If a person finds that sleep improves their symptoms, it could be useful ...

The multi-hyphenate actor shares her journey at the 2024 Women’s Health Health Lab. Kristin Chenoweth “owns” every stage she ...

All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom.

In a randomized triple-blinded controlled trial, probiotic and vitamin D supplementation did not significantly change ...

Shopping the best Amazon Prime Day deals? Don't skip out on the Renpho eye massager, which has the backing of 25,000 shoppers ...

Explore the impact of severe migraine and discuss the critical need for conversation between health care providers and ...

The funding will support the trial, premarket approval application and initial commercial launch of a system that could ...